Guest Editors Martin Kolb is a German–Canadian physician who obtained his MD at the Julius-Maximilian University Medical School in Wurzburg,¨ Germany. He received extensive training in clinical and anatomical pathology in Nurnberg, ¨ Germany, before he enrolled in general internal medicine and intensive care. He specialised in respiratory medicine and was board-certified for this discipline and for internal medicine in 2002, then received his PhD equivalent the following year. Currently, Martin Kolb is Associate Professor of Medicine at McMaster University, Hamilton, ON, Canada, as well as Director of the Division of Respirology and Research Director of the Firestone Institute for Respiratory Health, also in Hamilton. He looks after several hundred patients with interstitial lung disease in his specialty clinic and also practises in general respirology. He is on the medical staff at St Joseph’s Healthcare Hamilton, for respirology and general internal medicine. In addition, Martin Kolb is Deputy Editor for Respirology, the official journal of the Asian Pacific Society of Respirology and Academic Editor for PLoS One. He is on the Editorial Boards of the American Journal of Respiratory and Critical Care Medicine, the European Respiratory Journal (ERJ) and the European Respiratory Review. Martin Kolb is on the Executive Committee for the Respiratory Cell and Molecular Biology Assembly of the American Thoracic Society (ATS) and Chair of the Lung Injury and Repair Group of the European Respiratory Society (ERS). Martin Kolb’s major research area is focused on mechanisms of lung injury, repair and fibrosis, particularly in idiopathic pulmonary fibrosis. He has a strong interest in growth factor biology, extracellular matrix and mesenchymal cell progenitors. In his lab he uses a variety of animal models to study disease mechanisms and also the efficacy of novel drugs in the preclinical setting. In addition, he leads activities in biomarker development for lung fibrosis and he participates as Principal Investigator and Steering Committee member in numerous clinical trials on interstitial lung disease. Martin Kolb has over 80 peer-reviewed publications and has received funding from the Canadian Institutes of Health Research (CIHR), the National Institutes of Health, the Canadian Foundation for Innovation, the Ontario Thoracic Society and others. He has received career awards from the Parker B. Francis Families Foundation, the Dept of Medicine at McMaster University and the New Investigator Award from the CIHR. Eur Respir Monogr 2013 62: vii–viii. Copyright ERS 2013. DOI: 10.1183/1025448x.10011313 Print ISBN: 978-1-84984-044-6 Online ISBN: 978-1-84984-045-3 Print ISSN: 1025-448x Online ISSN: 2075-6674 Martin Kolb vii
Previous Page Next Page